Very early results, but it's exciting stuff. I am less confident in this specific trial working out than I am in some therapies in this field making significant progress in the next few years. (As usual, I am reminded how terribly slow research is for people that need treatments now.)
I was trying to figure out what the actual intervention was, and what clinical trial this is from based on the extremely limited information, and have not been able to yet.
In the mean time, here's 25 clinical trials for oncolytic viral therapies for pancreatic cancer:
Adenoviruses are very easy to make with custom contents, and are used for many many purposes. However they rarely make it all the way to become a therapy in practice.
It's always fascinating what hits the front page of HN when it comes to bio!
Is it normal to not report how many people received the treatment and just report the number of successes? Is this better than placebo or doing nothing?
It sounds like it might've been the first three people to receive the treatment at all. 15 more are going to be given higher doses next to hunt for an optimum level.
I think with trials involving experimental life saving treatment for terminal illnesses, doing things like control groups and placebos isn't considered particularly ethical, since you'd be giving false hope to someone who is knocking on death's door.
It's normal for a Phase 1 trial, which evaluates safety and dosing on a small number of participants. If the drug passes, more extensive trials will be done.
Why test against a placebo when you can test against death?
Although not 100%, almost all terminal patients will die. If you select your test group well so they are very likely to die, then you improve the information you get from the test, favor the class of patients who are most likely to benefit from the treatment and least likely to be harmed by it overall.
Very early results, but it's exciting stuff. I am less confident in this specific trial working out than I am in some therapies in this field making significant progress in the next few years. (As usual, I am reminded how terribly slow research is for people that need treatments now.)
In the mean time, here's 25 clinical trials for oncolytic viral therapies for pancreatic cancer:
https://clinicaltrials.gov/search?cond=Pancreatic%20Cancer&i...
And here's a review article on the general concept from the lead physician-researcher in this article:
https://pmc.ncbi.nlm.nih.gov/articles/PMC6186423/
Adenoviruses are very easy to make with custom contents, and are used for many many purposes. However they rarely make it all the way to become a therapy in practice.
It's always fascinating what hits the front page of HN when it comes to bio!
I think with trials involving experimental life saving treatment for terminal illnesses, doing things like control groups and placebos isn't considered particularly ethical, since you'd be giving false hope to someone who is knocking on death's door.
Although not 100%, almost all terminal patients will die. If you select your test group well so they are very likely to die, then you improve the information you get from the test, favor the class of patients who are most likely to benefit from the treatment and least likely to be harmed by it overall.
https://www.newscientist.com/article/2528235-pancreatic-canc...